GLP-1 receptor agonists such as semaglutide and tirzepatide are FDA-regulated for chronic weight management in adults with a BMI of 30 or higher, or 27 with a weight-related condition. Las Vegas runs around the clock, and dealers, servers, performers and resort staff working overnight and rotating shifts rarely fit a daytime clinic into their week - even as the job keeps appearance and stamina front of mind. Telehealth works on their clock: a licensed Nevada physician reviews your online assessment under Nevada Revised Statutes §629.515, and compounded medication from an FDA-registered 503B pharmacy ships to your Las Vegas address. Monthly cost runs $199–$379 versus about $1,247 for brand-name Ozempic or Wegovy. Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Serving Las Vegas ZIP codes: 89101, 89102, 89104, 89109, 89119.
Local clinics serving Sun City Summerlin: LightFit, TrimBody M.D. Summerlin and Perpetual Health Group. Many patients compare these in-person options against licensed GLP-1 telehealth — prescribed online, shipped to the door.
For Sun City Summerlin residents, the essentials on semaglutide. Semaglutide is today's benchmark molecule for GLP-1 weight-loss programs, with clinical trials (STEP) showing an average loss of about 15% of body weight over 68 weeks.
Price also shifts with the dose: the lowest titration steps usually cost less than the target maintenance dose. Beyond the sticker price, look at what is included: consultation, titration, refills, and shipping are sometimes bundled into a single monthly fee.
Local landmark: LightFit (1875 Village Center Cir #100, Las Vegas, NV 89134), rated 5/5 across 364 reviews. On the cost side, expect about $200-500/month compounded via telehealth; about $1,000-1,350/month brand-name without insurance. Semaglutide belongs to the 'GLP-1 receptor agonist (incretin analog)' class and is given as a weekly subcutaneous injection. Associated brands include Ozempic, Wegovy, Rybelsus.
Coverage varies by plan and indication; many patients without coverage opt for a compounded formula at a fixed monthly cost.
Ozempic is a brand of semaglutide dosed for diabetes; Wegovy is the same active ingredient dosed for weight loss. Semaglutide is the shared generic molecule.
Most patients notice reduced appetite within the first 1-2 weeks; clinically meaningful weight loss usually appears between week 8 and week 12 as the dose increases.
Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Licensed in Nevada. All prescriptions issued under Nevada Revised Statutes §629.515 and supervised by Nevada State Board of Medical Examiners.